Literature DB >> 10456610

Decreased antimicrobial resistance after changes in antibiotic use.

D W Smith1.   

Abstract

Vancomycin-resistant enterococci (VRE) and methicillin-oxacillin-resistant Staphylococcus aureus (MRSA) originally predominated in large medical centers; however, these isolates are now common in community hospitals and community clinics. No simple answer is available regarding control of antimicrobial-resistant bacteria, especially VRE and MRSA, as their numbers increase and pose a more serious threat to patient care. The source of colonization is often difficult to identify because of transport of patients among different locations on the continuum of care (e.g., hospital to extended care facility to home and back). At one hospital, control strategies greatly reduced the occurrence of gram-negative bacteria such as VRE. Since 1994, VRE declined from 16% to 5%. Similarly, the number of MRSA isolates declined from 35% to 23%. These declines are attributed to a cohesive working relationship among pharmacists, microbiologists, and infectious disease physicians and personnel, and to a decision to decrease administration of cephalosporins in favor of piperacillin-tazobactam.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456610     DOI: 10.1592/phco.19.12.129s.31702

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

Review 3.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 4.  Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.

Authors:  David L Paterson; Carlene A Muto; Magdaline Ndirangu; Peter K Linden; Brian A Potoski; Blair Capitano; Robert A Bonomo; David C Aron; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

6.  Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis.

Authors:  Janeane Hails; Felicia Kwaku; A Peter Wilson; Geoff Bellingan; Mervyn Singer
Journal:  Intensive Care Med       Date:  2003-01-31       Impact factor: 17.440

7.  Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.

Authors:  J A McKINNELL; D F Kunz; S A Moser; S Vangala; C-H Tseng; M Shapiro; L G Miller
Journal:  Epidemiol Infect       Date:  2016-06       Impact factor: 4.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.